A novel two-stage screen platform has recently been reported to accelerate the development of HDAC6, HDAC8, or dual HDAC6/8 inhibitors, which can alleviate PF progression in various animal models (Yu et al., 2023). Here, HDAC6 is linked to pemphigus foliaceus.